Superior safety profile of Regadenoson versus adenosine in patients with chronic obstructive pulmonary disease undergoing radionuclide myocardial perfusion imaging

被引：0

作者：

Senior, R. ^{[1
]}

Jacobsen, A. N. ^{[1
]}

Kinsey, C. ^{[1
]}

Dwivedi, G. ^{[1
]}

Olmsted, A. ^{[2
]}

Nguyen, P. ^{[1
]}

机构：

[1] Northwick Pk Hosp & Clin Res Ctr, Dept Cardiol, Harrow HA1 3UJ, Middx, England

[2] Cardiovasc Therapeut, Palo Alto, CA USA

来源：

EUROPEAN HEART JOURNAL | 2007年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：721 / 721

页数：1

共 50 条

[21] Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease [J].

Tanja Kero ;

Antti Saraste ;

Bo Lagerqvist ;

Jens Sörensen ;

Essi Pikkarainen ;

Mark Lubberink ;

Juhani Knuuti .

Journal of Nuclear Cardiology, 2022, 29 :24-36

[22] Myocardial Perfusion Reserve is Impaired in Patients with Chronic Obstructive Pulmonary Disease: a Quantitative Myocardial Perfusion MRI Study [J].

Nakamori, Shiro ;

Onishi, Katsuya ;

Nakajima, Hiroshi ;

Nagata, Motonori ;

Ishida, Masaki ;

Kitagawa, Kakuya ;

Dohi, Kaoru ;

Nakamura, Mashio ;

Sakuma, Hajime ;

Ito, Masaaki .

CIRCULATION, 2011, 124 (21)

[23] Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma [J].

Salgado Garcia, Carlos ;

Jimenez Heffernan, Amelia ;

Sanchez de Mora, Elena ;

Ramos Font, Carlos ;

Lopez Martin, Juana ;

Rivera de los Santos, Francisco ;

Ynfante Mila, Ignacio .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) :119-125

[24] Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma [J].

Carlos Salgado Garcia ;

Amelia Jimenez Heffernan ;

Elena Sanchez de Mora ;

Carlos Ramos Font ;

Juana Lopez Martin ;

Francisco Rivera de los Santos ;

Ignacio Ynfante Milá .

European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 :119-125

[25] SAFETY OF REGADENOSON AS A PHARMACOLOGIC STRESS AGENT FOR MYOCARDIAL PERFUSION IMAGING IN STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE PATIENTS NOT ON HEMODIALYSIS [J].

Ananthasubramaniam, Karthikeyan ;

Palani, Gurunanthan ;

Husain, Zehra ;

Karthikeyan, Aarthee ;

Karthikeyan, Vanji .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)

[26] Safety profile of bupropion for chronic obstructive pulmonary disease [J].

García-Río, F ;

Serrano, S ;

Mediano, O ;

Alonso, A ;

Villamor, J .

LANCET, 2001, 358 (9286) :1009-1009

[27] Regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in patients with bronchoconstrictive disease [J].

Salgado-Garcia, C. ;

Jimenez-Heffernan, A. ;

Sanchez de Mora, E. ;

Lopez-Martin, J. ;

Ramos-Font, C. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 :S245-S245

[28] First use in France of regadenoson within the context of radionuclide myocardial perfusion imaging: A comparative study versus dipyridamole [J].

Ait-Ali, J. ;

Palie, O. ;

Labbe, T. ;

Vinchon, F. ;

Prost, A. ;

Bruel, D. ;

Machefert, N. ;

Hachemi, M. ;

Robert, A. ;

Jadeau, C. ;

Boursot, C. .

MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (04) :396-400

[29] Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge [J].

Golzar, Yasmeen ;

Doukky, Rami .

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 :129-137

[30] CME Instructions: Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging [J].

Journal of Nuclear Cardiology, 2013, 20 (3) :334-335

← 1 2 3 4 5 →